PerkinElmer Announces New Share Repurchase Program

* Reuters is not responsible for the content in this press release.

Thu Oct 23, 2008 4:12pm EDT 

WALTHAM, Mass.--(Business Wire)--
PerkinElmer, Inc. (NYSE: PKI), a global leader in Health Sciences
and Photonics, today announced that its Board of Directors has
authorized the Company to repurchase up to 10 million shares of its
own common stock. Purchases will be made through open market
transactions or privately negotiated transactions, subject to market
conditions and trading restrictions.

   PerkinElmer, Inc. is a global technology leader driving growth and
innovation in Health Sciences and Photonics markets to improve the
quality of life. The Company reported revenue of $1.8 billion in 2007,
has approximately 9,100 employees serving customers in more than 150
countries, and is a component of the S&P 500 Index. Additional
information is available through www.perkinelmer.com or
1-877-PKI-NYSE.

Investor Relations:
PerkinElmer, Inc.
Michael A. Lawless, 781-663-5659
or
Media Contacts:
PerkinElmer, Inc.
Stephanie R. Wasco, 781-663-5701
stephanie.wasco@perkinelmer.com
or
Porter Novelli Life Sciences
Lynne H. Brum, 617-897-8258
LBrum@pnlifesciences.com

Copyright Business Wire 2008
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.